Page 1605 - Small Animal Internal Medicine, 6th Edition

Index 1577

Upper respiratory infections, feline, Urinary tract infections (Continued) Vaccines and vaccinations (Continued) Ventricular septal defect (Continued)
257–259 hyperthyroidism and, 791 canine distemper virus, 1454–1455 echocardiographic findings, 110–111,
110f
antibiotics for, 258, 1441t microbiology of, 670–671 canine infectious tracheobronchitis, electrocardiographic findings, 110
VetBooks.ir diagnosis of, 257–258 refractory, 706t canine influenza, 1455 etiology of, 110
324
clinical features of, 257
persistent, 705–706, 706t
canine parvoviral enteritis, 478
left-sided congestive heart failure
etiology of, 257
relapsing, 706t
associated with, 110
prevention of, 258–259
treatment of, 708–709, 1445–1446
for cats, 1452–1454
prognosis for, 259 subclinical, 709 canine parvovirus, 1454–1455 pathophysiology of, 110
treatment of, 258 Urinary tract zoonoses, 1542–1543 Chlamydia felis, 1453 prognosis for, 111
Urate urolithiasis Urine for dogs, 1454–1455 radiographic findings, 103t, 110
in cats, 721 appearance of, 664 feline calicivirus, 258–259, 1453 treatment of, 111
in dogs, 719–721, 720f, 720b bilirubin in, 665 feline herpesvirus, 258–259, 1453 Ventricular tachyarrhythmias
Urea, synthesis of, 658 chemical properties of, 664–665 feline immunodeficiency virus, 1454 acute therapy for, 82–84
Ureaplasma spp., 1441t, 1446, 1465 glucose in, 665 feline infectious peritonitis, 1454 algorithm for, 83f
clinical findings of, 1465 ketones in, 665 feline leukemia virus, 1453–1454 in Boxers, 148
diagnosis of, 1465–1466 occult blood in, 665 feline panleukopenia virus, 1453 chronic oral therapy for, 84
epidemiology of, 1464–1465 pH, 664–665 immune response mechanism of, description of, 82
etiology of, 1464–1465 physical properties of, 664 1451–1455 refractory, 83–84
prevention of, 1466 protein in, 665 immune-mediated hemolytic anemia treatment of, 83f
treatment of, 1466 sediment examination of, 665–670 secondary to, 1231 Ventricular tachycardia
zoonotic aspects of, 1466 casts, 667–668, 668f Leptospira interrogans, 1455 acute therapy for, 82–84
Urecholine. see Bethanechol crystals, 668–669, 669f–670f, 669t parainfluenza virus, 1455 chronic oral therapy for, 84
Uremia, 649, 693, 697 epithelial cells, 666–667, 667f pediatric, 1033, 1033f electrocardiography of, 41
Ureteral calculi, 715f, 716–719 organisms, 668, 669f rabies, 1125–1126, 1454–1455 intermittent paroxysms of, 42f
Ureteral obstruction, 715 red blood cells, 666, 666f rattlesnake, 1455 lidocaine for, 82
Ureteral stents, 716–717, 717f white blood cells, 666, 666f selection of, 1451–1452 polymorphic, 41
Ureterolithiasis, 714–722 specific gravity of, 652, 662–664, 741, types of, 1451 treatment of, 82–84
clinical signs of, 715, 715f 743f, 745f, 861–862 Vagal maneuver, 82 Ventricular wall stress, 55–56
diagnostic imaging of, 715–716, 715f Urine cortisol/creatinine ratio, 866t, 867, Vagina Ventrodorsal view, 14
medical treatment of, 716 867f–868f, 881, 881t artificial insemination through, 947 Verapamil
surgical intervention for, 716–719 Urine protein-to-creatinine ratio, hyperplasia of, in bitch, 957–958, 958f in cats, 90t–91t
ureteral stents, 716–717, 717f 661–662, 680–681, 698–699 Vaginal cytology, 941f characteristics of, 97
Ureters, ectopic, 730–732, 731f Urodynamic testing, 672, 732 Vaginal strictures, 980–982 in dogs, 90t–91t
Urethral bulking agents, 735 Urogenital disorders, 1025–1027, Vaginitis, 1446 dosage of, 90t–91t
Urethral closure pressure, 735–736 1025f–1027f, 1441t Vaginoscopes, 947–948, 948f negative inotropic effects of, 97
Urethral obstruction, 725 Urokinase, for arterial thromboembolism Vaginoscopy, 936–937, 936f–937f, 942, Vertebral heart score (VHS), 14–15, 14f
Urethral occluder, 735f in cats, 227b, 229 943f Vertebral tumors, 1146
Urethral plugs, 725, 725f Urokinase-type plasminogen activator, Vagolytic drugs, 97 Very-low-density lipoproteins, 908
Urethral pressure profile, 672, 732b 1388 Vagus nerve, 1056t, 1059–1060 Vestibular ataxia, 1046b
Urethral prolapse, 992 Urolith(s) Valium. see Diazepam Vestibular attacks, acute, 1116
Urethral sphincter mechanism analysis of, 712 Valvular pulmonic stenosis, 9 Vestibulocochlear nerve, 1056t
incompetence, 732–735, 732b calcium oxalate, 717–718 Vascular accidents, 1076–1077 Vestibulo-ocular reflex, 1056t
Urethral stones, 736 removal of, 712–714, 713f–714f Vascular endothelial growth factor Vestibulovaginitis, chronic, 980–982,
Urethrocystoscopy, 672 struvite, 718–719, 719f receptor, 1273 980f–982f
Urethroliths, 712 types of, 712 Vascular permeability edema, 357 Veterinary resources, for genetic disease,
Urinalysis, 544–545, 545f, 664–670 xanthine, 722 Vascular rings 936b
alimentary tract disease evaluations, Urolithiasis, 712–723 anomalies of, 116–117, 456–457, 458f Veterinary therapeutic diets, 904,
413 calcium oxalate obstruction of, 452–453, 458f 904t–906t
sediment examination, 665–670 dietary modifications for, 717–718, Vasodilators Vetoryl. see Trilostane
Urinary bile acid concentration, 536 718b amlodipine, 71 Viagra. see Sildenafil citrate
Urinary disorders drug therapy for, 718 heart failure treated with, 61–63, 64t, Vibramycin. see Doxycycline
clinical approach to, 649–650 management of, 717b 71–72, 129 Vincristine, 1225t, 1229, 1255t–1256t
cystometrography of, 672 prevention of, 717–718 prazosin, 71 Viokase V, 440
diagnostic imaging of, 671 cystine, 721–722 Vasopressin, 655–656 Viral arthritis, 1201
dysuria, 652–653, 653b signs of, 712 Vector borne disease, pregnancy loss Viral diseases, 1485–1501
hematuria, 650–652, 650f, 651b silica, 721–722, 722f and, 966 canine distemper virus, 1485–1487
history for, 649 urate Vena caval syndrome. see Caval clinical features of, 1485–1486, 1486t
microbiology of, 670–671 in cats, 721 syndrome diagnosis of, 1125, 1486–1487
physical examination of, 649–650 in dogs, 719–721, 720f, 720b Vena caval thrombosis, 233 etiology of, 1485
polydipsia, 213, 649, 653–656, xanthine, 722 Venipuncture, 1394 medallion lesions from, 1486f
654t–655t, 740–741, 741t Ursodeoxycholic acid Venodilators, 71–72 pathogenesis of, 1485
polyuria, 213, 653–656, 654t–655t, for lymphocytic cholangitis, 571–572 Venous thrombosis, 233–234 prevention of, 1487
740–741, 741t for neutrophilic cholangitis, 570 Ventilation/perfusion ratio, 316 signs of, 1124
radiography of, 671 Ursodiol, 590 Ventilatory support, 385–386 treatment of, 1487
renal biopsy of, 672–673 Usual interstitial pneumonia, 349–350 Ventricular ectopy vaccination for, 1454–1455
ultrasonography of, 671 Uterine contractions in arrhythmogenic right ventricular zoonotic aspects of, 1487
urethrocystoscopy of, 672 oxytocin effects on, 969–972 cardiomyopathy, 148 feline coronavirus, 1488–1491
urodynamic testing of, 672 patterns of, 969 Holter monitoring for, 143–144 clinical features of, 1488–1489
Urinary incontinence suppression of, terbutaline for, 962 Ventricular fibrillation, 41, 43f diagnosis of, 1489–1490
definitions of, 730–737 Uterine inertia, 969 Ventricular gallop, 9 enteric, 1488
ectopic ureters as cause of, 730–732, Uterus Ventricular hypertrophy, 55 epidemiology of, 1488
731f postpartum disorders involving, Ventricular outflow obstruction, 11, etiology of, 1488
overactive bladder as causes of, 974–979 105–109 prevention of, 1491
736–737 rupture of, 976 Ventricular preexcitation, 44–45, 45f treatment of, 1490–1491
overflow, 735–736 torsion of, 973f Ventricular premature complexes, 77–79 zoonotic aspects of, 1491
types of, 730–737 trauma to, 976, 976f compensatory pause associated with, feline immunodeficiency virus. see
ultrasonography of, 731f, 736f Uveitis, lens-induced, 829 40 Feline immunodeficiency virus
urethral closure pressure increases as V dilated cardiomyopathy and, 142 feline leukemia virus. see Feline
cause of, 735–736 electrocardiography of, 40 leukemia virus
urethral sphincter mechanism Vaccines and vaccinations treatment of, 83 myocarditis in puppies caused by, 153
incompetence, 732–735, 732b adverse reactions to, 1452 Ventricular remodeling, 55 Viral enteritis, 443
Urinary tract, 1054 attenuated, 1451 Ventricular septal defect Viral inclusion bodies, 1430
Urinary tract infections autoimmunity and, 1214 cardiopulmonary bypass for, 111 Viral myocarditis, 153
in cats, 791 Bordetella bronchiseptica, 1453, 1455 clinical features of, 110 Viral pneumonias, 340–343
complicated, 705t Borrelia burgdorferi, 1455 diagnosis of, 110–111, 110f Virbac. see Aglepristone
hyperadrenocorticism as cause of, 862 canine adenovirus, 1454–1455 dog breeds affected by, 102t Virbagen omega. see Interferon omega